ARTICLE SYNOPSIS...AbbVie's (ABBV) stock got slammed after disappointing results on small cell lung cancer drug, Rova-T, test results. The drug was the lead product of Stemcentrix, the biotech company ABBV acquired back in 2016 for $5.8 billion. On Thursday, March 22,
ARTICLE SYNOPSIS...The semiconductor HOLDRS is closing at the top of its 2005 range, and a reversal may be in the offing.
ARTICLE SYNOPSIS...A shooting star candlestick pattern indicates at least a pause in the uptrend.